We're #hiring a new Mobile Phlebotomist-Per Diem in New York, New York. Apply today or share this post with your network.
Sanguine Biosciences
生物技术研究
Woburn，Massachusetts 9,455 位关注者
Bridging the gap between researchers and patients
关于我们
Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridges the gap between patients and researchers through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services. Sanguine has supported translational, clinical, and cell & gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, shortening timelines and validating early-stage results to increase confidence and refine biomarkers in human trials. Four years in a row, Sanguine received the prestigious designation of a “Great Places to Work” company. In 2022, Sanguine was designated #2038 on the Inc. 5000 America’s Fastest Growing Private Companies list and achieved recognition on FORTUNE’s 100 Best Small Workplaces and Best Workplaces in Biopharma. Referenced in over 140 publications, Sanguine studies have appeared in high-impact journals, including Science, Nature, NEJM, Nature Medicine, and Science Translational Medicine. Popular media outlets featuring Sanguine include the Fox News Channel, The Washington Post, Inc.,The Boston Globe, Inc., and many others.
- 网站
-
https://www.sanguinebio.com
Sanguine Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Woburn，Massachusetts
- 类型
- 私人持股
- 创立
- 2010
- 领域
- Mobile Specimen Collection、Central Laboratory Processing、Registry Building、Patient Recruitment & Retention、Longitudinal Biomarker Banking、Observational Studies、Leukapheresis、Leukopaks、Longitudinal sample collection、Prospective Biospecimen collection、Cell isolation和Ready-to-ship Biospecimen Samples
地点
-
主要
获取路线
400 W Cummings Park
Suite 3050
US，Massachusetts，Woburn，01801
Sanguine Biosciences员工
动态
-
We're #hiring a new Salesforce Solutions Architect and Lead Administrator in United States. Apply today or share this post with your network.
-
Our PBMC inventory is growing?? Sanguine’s direct-to-donor approach to sample collection has allowed us to develop a vast biospecimen inventory, with healthy and disease-state PBMCs ready to ship from our freezer to yours! Find high-quality PBMCs and more: https://hubs.ly/Q039Jy560
-
-
If you need dermatological biospecimens, Sanguine can help. With 1,300+ diagnosed eczema, vitiligo, and CSU donors in our Donor Community, we have access to leukopaks, skin tapes, and other sample types to accelerate your dermatological research. Explore prospective and retrospective samples on our website: https://hubs.ly/Q039qMVq0
-
Spring savings! Now through the end of the month, get 10% off leukopak products, including LeukoCore? RUO healthy and disease-state leukopaks and LeukoLot? cryopreserved bulk PBMCs. Explore our 80+ disease-state and healthy products and save today! Leukopaks: https://hubs.ly/Q039f3R50 PBMCs: https://hubs.ly/Q039f5sz0
-
With over 2,000 donors representing 20+ rare diseases in our Donor Community, Sanguine is proud to support #RareDiseaseDay today. Learn more about how we can accelerate rare disease research together: https://hubs.ly/Q038NxWp0
-
The results are in! ?? In our recent poll, you voted to hear more about Systemic Lupus Erythematosus (SLE). With over 3,000 individuals diagnosed with SLE in our Donor Community, Sanguine can provide a variety of biospecimens and associated donor data, and accommodate complex I/E criteria. Learn more about our expertise in SLE sample collection: https://hubs.ly/Q038qJVN0
-
-
Congratulations to the team at The Janssen Pharmaceutical Companies of Johnson & Johnson on their recent publication! Using PBMCs collected by Sanguine from donors with specific subtypes of cryopyrin-associated periodic syndrome (CAPS), researchers from Janssen identified a promising clinical candidate for diseases associated with the NLRP3 inflammasome. Read the full article: https://hubs.ly/Q037ZByV0
-